FDA Approves First-Ever, Pan-Cancer Drug in Milestone for Personalized Medicine
From - Diagnostic Testing & Emerging Technologies In what is being heralded a major milestone for personalized medicine, in late May the U.S. Food and Drug Administration (FDA) approved the first… . . . read more
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article